0001104659-20-030294.txt : 20200306
0001104659-20-030294.hdr.sgml : 20200306
20200306181643
ACCESSION NUMBER: 0001104659-20-030294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190731
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ban Randy
CENTRAL INDEX KEY: 0001737127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38468
FILM NUMBER: 20696107
MAIL ADDRESS:
STREET 1: C/O INSPIRE MEDICAL SYSTEMS, INC.
STREET 2: 9700 63RD AVENUE NORTH, SUITE 200
CITY: MAPLE GROVE
STATE: MN
ZIP: 55369
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.
CENTRAL INDEX KEY: 0001609550
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 261377674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
BUSINESS PHONE: 763-957-5037
MAIL ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
4
1
a4.xml
4
X0306
4
2019-07-31
0
0001609550
Inspire Medical Systems, Inc.
INSP
0001737127
Ban Randy
C/O INSPIRE MEDICAL SYSTEMS, INC.
5500 WAYZATA BLVD., SUITE 1600
GOLDEN VALLEY
MN
55416
0
1
0
0
Chief Commercial Officer
Common Stock
2020-03-04
4
M
0
10000
1.14
A
10000
D
Common Stock
2020-03-04
4
S
0
1801
84.33
D
8199
D
Common Stock
2020-03-04
4
S
0
1673
85.19
D
6526
D
Common Stock
2020-03-04
4
S
0
1613
86.38
D
4913
D
Common Stock
2020-03-04
4
S
0
1730
87.40
D
3183
D
Common Stock
2020-03-04
4
S
0
3044
88.09
D
139
D
Common Stock
2020-03-04
4
S
0
139
89.10
D
0
D
Common Stock
167
I
By son
Common Stock
166
I
By daughter
Stock Option (Right to Buy)
67.63
2019-07-31
4
A
0
25000
0
A
2029-07-31
Common Stock
25000
25000
D
Stock Option (Right to Buy)
1.14
2020-03-04
4
M
0
10000
0
D
2023-09-12
Common Stock
10000
55187
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.88 to $84.77. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.91 to $85.43. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $86.73. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.98 to $87.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.02 to $88.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.04 to $89.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
The option is fully vested and exercisable.
This option grant was previously reported as having an expiration date of September 11, 2023, which has been revised herein.
/s/ Richard Buchholz, as Attorney-in-Fact for Randy Ban
2020-03-06